Nanomix Enters into Distribution Agreement for the eLab System and Future N ...

Caris Life Sciences Launches Whole Exome Sequencing with MI Exome

Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% ...

Inivata’s Nitzan Rosenfeld to Receive 2020 Cancer Researcher Award from the ...

NCCN Stresses the Importance of RNA Sequencing in Updated NSCLC Guidelines

Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Ge ...

Caris Life Sciences to Present Data Evaluating PI3K Pathway Alterations at ...

Caris Life Sciences and Ambry Genetics Partner to Advance Cancer Care

Inivata and the European Organization for Research and Treatment of Cancer ...

Caris Life Sciences to Present New Research Across Tumor Types at ESMO Cong ...

Inivata to Present New Clinical Data on the Utility of Liquid Biopsy and In ...

MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx Tes ...

Caris Life Sciences Accelerates Growth Through Development of Pioneering St ...

NanoString Technologies and Mayo Clinic Laboratories Enter Joint Developmen ...

Inivata announces launch of clinical trial to evaluate impact of InVisionFi ...

Inivata Signs Distribution Agreement with IPS Genomix for InVision® Genomic ...

NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimer’s ...

MDxHealth (R): Multi-center Study Validates SelectMDx's High Negative Predi ...

Caris Life Sciences Showcases Results from Novel Machine Learning Approach ...

Caris Life Sciences Partners with Debiopharm International SA to Develop Co ...

Caris Life Sciences Partners with Debiopharm International SA to Develop Co ...

Caris Life Sciences Receives FDA Breakthrough Device Designation for MI Tra ...

MDxHealth (R): MDxHealth Announces Positive Data from Pan-European Clinical ...

Inivata Publishes Positive Results of Clinical Validation and Utility Study ...

Inivata Receives Medicare Final Coverage Decision for InVisionFirst-Lung Li ...

MDxHealth : SelectMDx® Liquid Biopsy Test for Prostate Cancer Included in t ...

Caris Life Sciences Launches Whole Transcriptome Sequencing (WTS) with Nove ...

MDxHealth (R): SelectMDx Outperforms Prostate Health Index (phi) Blood Test ...

United Kingdom’s National Institute for Health and Care Excellence (NICE) R ...

MDxHealth (R): MDxHealth Announces Approval for SelectMDx for Prostate Canc ...

Prosigna Breast Cancer Assay Outperforms All Other Commercial Assays Tested ...

NanoString Technologies Highlights Presentation of Multiple Prosigna/PAM50 ...

Caris Life Sciences to Present Key Research Findings at the European Societ ...

Caris Life Sciences Announces Major Milestone of 100,000 Clinical Cases usi ...

Memorial Healthcare System Joins the Caris Centers of Excellence for Precis ...

Caris Life Sciences Designates USC Norris Comprehensive Cancer Center A Car ...

Caris Life Sciences Designates the Cancer Therapy & Research Center a Caris ...

Caris Life Sciences Introduces Research Showing Time-To-Next Treatment as E ...

NanoString Technologies Highlights Advances in Precision Oncology and Immun ...

Caris Life Sciences to Present Key Research Findings at the 2016 American S ...

Cigna Issues Positive Coverage Decision for NanoString's Prosigna® Breast C ...

Aetna Issues Positive Coverage Decision for NanoString's Prosigna® Breast C ...

Caris Life Sciences to Present Key Research Findings at the American Associ ...

Caris Life Sciences to Present Molecular Insights Informing Treatment Strat ...

Caris Life Sciences Announces Publication of Study Showing Nine-Month Overa ...

NanoString Technologies and Merck Expand Collaboration to Develop and Comme ...

American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Re ...

Caris Life Sciences to Present Data on Clinical Benefit of Caris Molecular ...

Caris Life Sciences to Present Research Supporting Clinical Utility of Cari ...

Caris Life Sciences Research Yields New Molecular Insights into Rare Breast ...

NanoString Technologies Announces Eleven Prosigna/PAM50 Presentations at th ...

Caris Life Sciences® and Fox Chase Cancer Center – Temple Health Collaborat ...

Caris Life Sciences to Present Research Supporting the Benefit of Precision ...

Clinical Validity of Molecular Profiling from Caris Life Sciences Confirmed ...

Caris Molecular Intelligence Tumor Profiling Identifies Potential Responder ...

New Clinical Data Demonstrate Clinical Utility of Caris Molecular Intellige ...

North Shore Hematology Oncology Associates Joins the Caris Centers of Excel ...

Caris Life Sciences Designates Fox Chase Cancer Center a Caris Center of Ex ...

Caris Life Sciences Presents New Tumor Profiling Research Providing Insight ...

Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and C ...

Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Com ...

Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted ...

Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clin ...

Caris Life Sciences Presents Large Cohort Biomarker Analyses that Character ...

Caris Molecular Intelligence Identifies Targeted Treatment Options for Pati ...

Caris Life Sciences Announces Presentation of Comprehensive Tumor Profiling ...

Caris Life Sciences Establishes the Caris Centers of Excellence for Precisi ...

Caris Life Sciences Designates MedStar Health a Caris Center of Excellence

Caris Life Sciences Vice Chairman Dr. Jonathan Knowles to Receive Personali ...

Caris Life Sciences and COTA Enter Collaboration to Measure Clinical and Ec ...

Caris Life Sciences’ Multiplatform Tumor Profiling Enhances Understanding o ...

Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles t ...

Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles t ...

Caris Life Sciences’ Multiplatform Tumor Profiling Technology Identifies Ex ...

Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Iden ...

Caris Life Sciences Demonstrates Clinical Utility of Tumor Profiling by Ide ...

Caris Life Sciences Announces Presentation of Comprehensive Tumor Profiling ...

NanoString Technologies' Prosigna Breast Cancer Assay Included in German Br ...

Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with ...

Caris Life Sciences’ Multiplatform Tumor Profiling Helps to Identify Potent ...

Caris Life Sciences Reports Record-Setting 2014 Year-End Results

NanoString Technologies to Release Fourth Quarter 2014 Financial Results an ...

West Cancer Center Designated a Center of Excellence by Caris Life Sciences ...

NanoString Technologies to Present at 2015 Leerink Global Healthcare Confer ...

Caris Life Sciences® Establishes the Caris Centers of Excellence for Precis ...

Caris Molecular Intelligence™ Identifies Therapeutic Options, Including Nov ...

Multiplatform Tumor Profiling from Caris Molecular Intelligence™ Identifies ...

Caris Life Sciences’ Multiplatform Tumor Profiling of Hepatocellular and Bi ...

NanoString Technologies Provides Update on 2014 Operational and Preliminary ...

NanoString Technologies to Present at J.P. Morgan 33rd Annual Healthcare Co ...

NanoString Technologies Highlights Important Results from Prosigna Decision ...

Caris Life Sciences® Presents Two Studies Demonstrating Utility of Tumor Pr ...

NanoString Technologies Updates Prosigna FDA Labeling to Provide Greater In ...

Caris Life Sciences Study Shows Molecular Profiling May Expand Use of PD-1 ...

Large Studies Show Caris Molecular Intelligence™ Identifies Targets with Th ...

NanoString Announces Publication in the Journal of Clinical Oncology Showin ...

NanoString Collaborates with Brigham and Women's Hospital in Boston to Acce ...

Number of Actionable Biomarkers in Urothelial Carcinoma (UC)

Tumour Profiling with Caris Molecular Intelligence Offers Hope For Patients ...

Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in ...

NanoString Announces Unexpected Death of Chief Medical Officer, J. Wayne Co ...

NanoString Technologies to Present at Upcoming Investor Conferences

Caris Life Sciences Collaborates with GenoSpace to Enhance Data Mining Capa ...

Feist-Weiller Cancer Center Partners With Caris Life Sciences to Establish ...

Caris Molecular Intelligence™ Identifies Key Biomarkers of Clinical Benefit ...

NanoString Technologies Receives Market Approval From the Australian Therap ...

NanoString Technologies Introduces New Universal Junction Probe Design for ...

Valley Medical Oncology Consultants Partners With Caris Life Sciences to Es ...

NanoString Technologies to Participate in the JMP Securities Healthcare Con ...

Caris Life Sciences Research Provides Key Clinical Insights on Immunotherap ...

Caris Life Sciences Presents Ground-breaking Registry Data Demonstrating Ca ...

Caris Life Sciences Biomarker Research Suggests Role for Immune-targeted Th ...

NanoString Technologies Enters into Biomarker Companion Diagnostic Collabor ...

Caris Life Sciences Comprehensive Tumor Profiling Research Reveals Numerous ...

Caris Life Sciences Presents Data Highlighting Utility of Multi-Technology ...

Caris Life Sciences Presents ASCO Molecular Profiling Data Identifying Addi ...

NanoString Technologies to Participate in the Jefferies 2014 Global Healthc ...

Caris Life Sciences Advances Precision Medicine for Cancer Patients through ...

NanoString Technologies Receives Canadian Market Approval for its Prosigna ...

NanoString Technologies to Participate in the 2014 Bank of America Merrill ...

Boston Business Journal Letter to the Editor: Cancer Patients Deserve to Kn ...

Caris Life Sciences Significantly Enhances Clinical Utility of World’s Lead ...

Newly Published Analytical Validation Study Shows Precision and Reproducibi ...

NanoString Technologies to Participate in the Cowen 34th Annual Health Care ...

North Shore Hematology Oncology Associates Partners With Caris Life Science ...

Study Confirms Ability of the Prosigna Assay to Assess Risk of Late Distant ...

NanoString Technologies Launches Commercial Reagents to Enable Laboratories ...

Multi-Platform Tumor Profiling Research in Bladder and Prostate Cancers Yie ...

NanoString Technologies to Participate in the Leerink Swann Global Healthca ...

Large International Tumor Profiling Study of Colorectal Cancer Provides Key ...

Multi-Platform Tumor Profiling Identifies Actionable Drug Targets, Potentia ...

Tumor Profiling Studies on Difficult-to-Treat Gastrointestinal Cancers Aid ...

NanoString Technologies to Present at the JP Morgan 32nd Annual Healthcare ...

Caris Life Sciences’ Multiplatform Tumor Profiling Enhances Understanding o ...